Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1984-6-28
|
pubmed:abstractText |
The difference in the hearing threshold before and after treatment with cis-diaminnedichloroplatinum (DDP) is analysed in 69 patients. Hearing loss due to DDP treatment is mainly limited to 8,000 Hz and the incidence is about 40%. The effect of DDP is dose-related, although even at the lowest dose 20% of the patients are affected. The age of the patients is not an important factor. Loss of hearing due to DDP treatment occurs independent of any pre-existent hearing loss although those patients with great pre-existent hearing loss do not show a further loss. Of the patients with hearing loss, 39% show a difference of 20 dB or more between the left and the right ear. Hearing loss due to DDP is of minor importance compared with many of the other side-effects of DDP.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0302-9530
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
239
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
255-62
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:6539589-Auditory Threshold,
pubmed-meshheading:6539589-Cisplatin,
pubmed-meshheading:6539589-Dose-Response Relationship, Drug,
pubmed-meshheading:6539589-Female,
pubmed-meshheading:6539589-Hearing Loss,
pubmed-meshheading:6539589-Hearing Loss, High-Frequency,
pubmed-meshheading:6539589-Humans
|
pubmed:year |
1984
|
pubmed:articleTitle |
Analysis of hearing loss due to cis-diamminedichloroplatinum-II.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|